Literature DB >> 11021469

Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.

A Da Costa1, T Chalvidan, A Belounas, M Messier, M Viallet, H Mansour, D Lamaison, P Djiane, K Isaaz.   

Abstract

INTRODUCTION: Death due to acquired torsades de pointes usually is caused by ventricular fibrillation (VF), but the contributing factors to VF triggered by pause-dependent torsades de pointes are not understood. METHODS AND
RESULTS: We evaluated 91 patients who fulfilled four criteria: (1) pause-dependent torsades de pointes; (2) prolonged QT interval and/or corrected QT (QTc) (>0.44 sec); (3) long-short initiation sequence; and (4) conditions known to induce pause-dependent torsades de pointes. There were 38 patients with a documented VF (group I) and 53 without VF (group II). Absolute and relative dispersions of QT and QTc were calculated based on the 12-lead standard ECG. Group I differed from group II with regard to myocardial infarction history (32% vs 13%; P = 0.035), left ventricular ejection fraction (44% +/- 14% vs 65% +/- 9%; P < 0.0001), presence of structural heart disease (100% vs 20.8%; P < 0.0001), QT mean (591 +/- 73 msec vs 514 +/- 78 msec; P < 0.0001), QTc mean (563 +/- 76 msec vs 508 +/- 90 msec; P = 0.002), absolute QT dispersion (166 +/- 56 msec vs 84 +/- 49 msec; P < 0.0001), relative QT dispersion (9.9% +/- 3.5% vs 6.3% +/- 3.2%; P < 0.0001), absolute QTc dispersion (158 +/- 57 msec vs 81 +/- 44 msec; P < 0.0001), and relative QTc dispersion (9.9% +/- 3.6% vs 6.2% +/- 3%; P < 0.0001). Multiple regression analysis showed that ejection fraction (P = 0.0001), presence of structural heart disease (P < 0.0001), and relative QTc dispersion (P = 0.038) were the only independent predictors of VF.
CONCLUSION: Left ventricular function, presence of structural heart disease, and QTc relative dispersion should be evaluated carefully in patients with conditions susceptible to inducing torsades de pointes.

Entities:  

Mesh:

Year:  2000        PMID: 11021469     DOI: 10.1111/j.1540-8167.2000.tb00171.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

1.  Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.

Authors:  Takayuki Sekihara; Eisaku Nakane; Kazutaka Nakasone; Moriaki Inoko
Journal:  BMJ Case Rep       Date:  2016-10-25

2.  Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.

Authors:  Borje Darpo; Dilip R Karnad; Fabio Badilini; Jeff Florian; Christine E Garnett; Snehal Kothari; Gopi Krishna Panicker; Nenad Sarapa
Journal:  Br J Clin Pharmacol       Date:  2014-03       Impact factor: 4.335

3.  Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.

Authors:  Borje Darpo; Georg Ferber; Peter Siegl; Bart Laurijssens; Fiona Macintyre; Stephen Toovey; Stephan Duparc
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 4.  Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?

Authors:  Jem D Lane; Andrew Tinker
Journal:  Front Physiol       Date:  2017-11-06       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.